Skip to main content
. Author manuscript; available in PMC: 2020 Jul 15.
Published in final edited form as: Acta Biomater. 2019 Jan 31;93:222–238. doi: 10.1016/j.actbio.2019.01.061

Figure 5.

Figure 5.

Cells and Cell-based Products as Drug-Delivery Mechanisms. MSCs are isolated from either bone marrow or adipose tissue, expanded, and [A] injected into the joint to deliver bioactive factors. Cultured MSCs can also be used to isolate the therapeutic exosomes for [B] more controlled and precise delivery of factors. [C] Genetic modification of cultured cells or direct delivery of the vector into the joint can modify cells to provide local and sustained production of therapeutic factors.